CEPI expands Clover partnership on COVID-19 vaccine

By The Science Advisory Board staff writers

July 8, 2020 -- The Coalition for Epidemic Prepardeness Innovations (CEPI) has expanded its partnership with Clover Biopharmaceuticals for the development and manufacture of Clover's COVID-19 S-Trimer vaccine candidate.

The vaccine is based on Clover's Trimer-Tag vaccine technology platform. S-Trimer resembles the native trimeric SARS-CoV-2 spike protein and is produced via a rapid mammalian cell-culture based expression system.

Through the partnership, CEPI will invest an additional $66 million in upfront payment that will fund preclinical studies, a phase I clinical trial, and preparation of global sites for further clinical development. A phase I clinical trial began enrolling participants on June 19.

Meanwhile, Clover is scaling up its manufacturing capacity to allow for the production of hundreds of millions of doses per year. If clinical development is successful, the partnership agreement indicates that CEPI will provide additional funding to bring the S-trimer vaccine candidate through licensure in China and globally.

CEPI, Clover to partner on COVID-19 vaccine
The Coalition for Epidemic Preparedness Innovations (CEPI) and Clover Biopharmaceuticals Australia plan to partner on the development of a COVID-19 vaccine.
COVID-19 vaccine candidates show progress amid challenges
As the COVID-19 outbreak advances worldwide, companies are stepping up to the challenge to develop a potential vaccine. There are over 75 confirmed COVID-19...
Dynavax, Clover partner for protein-based COVID-19 vaccine
A new research collaboration between Dynavax Technologies and Clover Biopharmaceuticals aims to develop a vaccine candidate to prevent COVID-19. The partnership,...

Copyright © 2020 scienceboard.net


Conferences
Glasgow International Health Festival
August 24-27
Glasgow, Glasgow City United Kingdom
Pharma Competitive Intelligence Conference and Exhibition
September 21-22
Newark, New Jersey United States
BioProcess International (BPI) Conference
September 27-30
Boston, Massachusetts United States
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter